NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

Honestly, I’d vote Yes if they would just explain the reason for the delay and why the MAA approval is stuck. I don’t really care whether they have a buyout lined up or not—what shareholders need before voting “Yes” is simply the truth. Even though I hold over a million shares, my individual “Yes” or “No” vote may not matter much, but I still want transparency.
Here’s my assumption: I think management already knew there would be a long delay, even before the Advent merger, and that this was one of the reasons they moved forward with it. By showing the merger as progress, they could justify requesting dilution at the ASM while waiting for approval.
As someone mentioned, if Merck is supposedly building major facilities for Northwest, why can’t they lend us $25 million if they truly believe in eventually acquiring Northwest Bio outright? If my guess is correct, the partner they have in mind may not even be a large company—maybe something more comparable to our size. But honestly, I don’t care whether the partner is big or small, because once approval comes through, everything changes anyway.